Clinical Scorecard: Risk Model Stratifies Heart Failure Outcomes
At a Glance
| Category | Detail |
|---|---|
| Condition | Heart Failure with Preserved or Mildly Reduced Ejection Fraction |
| Key Mechanisms | Biomarker-driven risk model stratifying outcomes based on clinical variables and biomarkers. |
| Target Population | Patients aged 40 years or older with symptomatic heart failure and left ventricular ejection fraction of 40% or greater. |
| Care Setting | Outpatient and inpatient settings, following randomized trial protocols. |
Key Highlights
- Event rates for heart failure hospitalization or cardiovascular death increased significantly across risk quintiles.
- Finerenone consistently reduced composite outcomes across all risk quintiles.
- Absolute risk reduction varied significantly by baseline risk, with lower numbers needed to treat in higher-risk groups.
- Adverse events such as hyperkalemia and elevated creatinine were more common with finerenone compared to placebo.
- Baseline risk did not modify the relative treatment effect of finerenone.
Guideline-Based Recommendations
Diagnosis
- Utilize the EMPEROR-Preserved risk model for stratifying heart failure risk.
Management
- Consider finerenone for patients with heart failure and preserved ejection fraction, especially in higher-risk groups.
Monitoring & Follow-up
- Monitor for adverse effects such as hyperkalemia and elevated creatinine, particularly in higher-risk patients.
Risks
- Be aware of increased incidence of hypotension, elevated creatinine, and hyperkalemia with finerenone.
Patient & Prescribing Data
Patients with symptomatic heart failure and preserved or mildly reduced ejection fraction.
Finerenone shows greater absolute benefits in higher-risk patients, with a significant reduction in heart failure hospitalization and cardiovascular death.
Clinical Best Practices
- Implement a biomarker-driven approach for risk stratification in heart failure patients.
- Tailor treatment strategies based on individual risk profiles.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
